Increasing Physical Activity Among Medical Inpatients by Digital Nudging of Patients and Staff

NCT ID: NCT06983977

Last Updated: 2025-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-19

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sedentary behaviour among medical inpatients is strongly associated with hospital-associated functional decline and poses a severe threat to patients' functional capacity and independency. High human and socioeconomic costs underline the urgency to find solutions to this world-wide problem.

Objective: This multicentre study, including a total of 400 patients from Copenhagen, Aalborg, Tórshavn, and Nuuk, will assess the effect of a digital intervention that aims to reduce sedentary behaviour and increase physical activity in medical inpatients.

Intervention: Digital feedback and nudging regarding the patients' physical activity levels to patients and healthcare staff Design: Stepped-wedge cluster randomised multicentre trial Primary outcome: Daily average time of patients' physical activity (minutes).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Activity Inpatients Digital Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Measurement of physical activity

Group Type OTHER

Measurement of physical activity

Intervention Type OTHER

Measurement of physical activity by accelerometer

Intervention

Digital feedback and nudging to participant and staff regarding participants' physical activity levels

Group Type EXPERIMENTAL

Digital nudging

Intervention Type OTHER

Digital feedback and nudging to participants (patients) and staff, based on participants' physical activity measurements, aiming to increase patients' physical activity and reduce sedentary time

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurement of physical activity

Measurement of physical activity by accelerometer

Intervention Type OTHER

Digital nudging

Digital feedback and nudging to participants (patients) and staff, based on participants' physical activity measurements, aiming to increase patients' physical activity and reduce sedentary time

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to one of the participating wards
* Has understood and signed informed consent
* Reads and understands Danish, Faroese, Greenlandic or English

Exclusion Criteria

* Has an expected hospitalisation less than 24 hours after potential recruitment
* Is not able to give informed consent to participate in the study
* Has allergy towards band aid
* Not able to (shortly) stand in an upright position even with maximal assistance
* There are contraindications for the patient to mobilise or be physically active due to unstabilized acute medical conditions, including, but not limited to, acute aortic dissection, -myocardial infarction, -pulmonary embolism, -sepsis.
* There are ethical concerns regarding the patients' participation in the study, including, but not limited to, the patient being:

* In the terminal phase of life
* In a crisis state regarding their disease/situation and deemed unfit for participation

To ensure medically responsible inclusion of patients, the project personnel will consult and confer with the treatment responsible medical doctor, or their delegate, before including a potential participant for the trial.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bispebjerg Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christian Dall

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian H Dall, Associate professor, PhD

Role: PRINCIPAL_INVESTIGATOR

Bispebjerg Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bispebjerg Hospital

Copenhagen, Capital Region, Denmark

Site Status RECRUITING

Aalborg University Hospital

Hobro, North Denmark, Denmark

Site Status RECRUITING

National Hospital

Tórshavn, , Faroe Islands

Site Status RECRUITING

Queen Ingrids Hospital

Nuuk, , Greenland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark Faroe Islands Greenland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Durita V Gunnarsson, PhD student, MSc.

Role: CONTACT

+45 26472857

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christian H Dall, Associate professor, PhD

Role: primary

+45 28604402

Dall

Role: backup

Michael S Rathleff, Professor, Dr. Med.

Role: primary

+45 22117002

Rathleff

Role: backup

Durita V Gunnarsson, PhD student, MSc.

Role: primary

+45 26472857

Sonja Sørensen, MSc., Physiotherapist

Role: primary

+299 344741

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VMK-2403916

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Effect of Exercise on Prescription
NCT00399997 UNKNOWN PHASE2/PHASE3